NINGXIA QIYUAN PHARMACEUTICAL CO.,LTD.

Ningxia Qiyuan Pharmaceutical Co., Ltd. (hereafter called Qiyuan Pharma.) was incorporated from former Ningxia Pharmaceutical Factory & Ningxia Chinese Traditional Medicine Factory since Jan. 2001. Through development of more than 20 years, the company has been a well-known modern large-scale comprehensive biopharmaceutical enterprise in China and abroad.

The company relies on suitable biopharmaceuticals environmental conditions in Ningxia’s regional, dedicated on development and production of antibiotic APIs, Vitamin APIs and deep processing of corn. In the field of Tetracycline and Erythromycin APIs, the company is one of the 3 world's three largest suppliers, the Vitamin C series products occupy a place in the domestic and international markets due to their scale and quality.

Qiyuan Pharmaceutical has been recognized as a high-tech enterprise, with an enterprise technology center and a postdoctoral research workstation. The company's Erythromycin and Tetracycline Hydrochloride APIs have got certifications from the US FDA, European COS, and EUGMP certification, and passed official quality audits in multiple countries, such as India, Japan etc. Vitamin C products have also passed international food certifications, such as HALAL, KOSHER etc. The company's products are widely sold to dozens of countries and regions, including Europe, South America, Africa, Southeast Asia etc. The registered trademark "Qiyuan" of the company has been recognized as a "Famous Trademark of Ningxia" by the Administration for Industry and Commerce of Ningxia Hui Autonomous Region for many times.

The company has been awarded multiple honorary titles, including "AAA Integrity Pharmaceutical Enterprise" and "A-Level Tax Credit Unit" in the autonomous region, and "Contract Abiding and Creditworthy Enterprise" in the country, autonomous region, and Yinchuan city.

NINGXIA QIYUAN CHINESE MEDICINE CO.,LTD.

Ningxia Qiyuan National Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Qiyuan Industrial Investment, which is a high-tech enterprise established in 2001. The company integrates scientific research, production and sale, and has been recognized as the "Enterprise Technology Center", "Technology Innovation Center for Traditional Chinese Patent Medicines of Ningxia" and "Specialized and Innovative Example Enterprise". The company has production capacity of Chinese and Western medicine preparations with five major dosage forms, including tablet, granule, capsule, pill, and suppository, health foods and traditional Chinese medicine extracts. The main products include Jinlian Qingre series, goji berry series, hawthorn essence lipid-lowering series, and Vitamin C series. The company adheres to enterprise purpose of "Building Reputation in World, Promoting Healthy China" and value concept of "Caring Employees, Advocating Creativity", and has been a key enterprise in the pharmaceutical industry in Ningxia.

NINGXIA QIYUAN MEDICINE CO.,LTD.

Ningxia Qiyuan Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Qiyuan Industrial Investment, which is established in 2002, focused on pharmaceutical distribution, wholesale, and retail chain businesses. The company mainly deals in traditional Chinese patent medicines and Chinese medicinal herbs, Chinese herbal decoction pieces, chemical APIs and their preparations, antibiotics and their preparations, biochemical drugs, biological products, Class II psychotropic drugs, anabolic agents and peptide hormones, medical devices etc. In Ningxia region, we own many directly operated chain pharmacies. The company has perfect quality management system, advanced facilities and equipment, the information management system is also equipped, which can achieve full process quality control of drug procurement, storage and sale etc.

NINGXIA YUYUAN BIOTECHNOLOGY CO.,LTD.

Ningxia Yuyuan Biotechnology Co., Ltd. is a wholly-owned subsidiary of Ningxia Qiyuan Pharmaceutical Co., Ltd., established in October 2014 with a registered capital of 20 million RMB. The company covers an area of 483333 m2 (approximately 725 acres), which the building area is 8000 m2. As a high-tech enterprise which is based on biochemical production, Yuyuan Biotechnology has mature technology on D-sorbitol production field and is the exclusive producer within autonomous region, which has obvious regional advantages and excellent product quality control.

The main products include D-sorbitol and hydrogen gas. The hydrogen gas is used for D-sorbitol production, and major industrial raw material, industrial gas and specialty gas.